Lilly

2011 Lilly Global Day of Service Focuses on Healthy Outdoor Living

Volunteers work around Indianapolis to improve community spaces and promote wellness
Press Release

(3BL Media / theCSRfeed) Indianapolis – October 4, 2011 – Thousands of volunteers from Eli Lilly and Company (NYSE: LLY) will work from dawn to dusk on Thursday, Oct. 6, with Keep Indianapolis Beautiful, Inc. (KIB), and 30 partner organizations to revitalize four Indianapolis corridors during the 2011 Lilly Global Day of Service.

LillyPad, Our Company Blog: Fighting MDR-TB, Together

Blog

October 27th, 2011 | By: David Marbaugh

Bonjour! Greetings from Lille, France, where we just announced the third stage of The Lilly MDR-TB Partnership, our program to help fight against multidrug-resistant tuberculosis – a disease that kills more than 150,000 people each year.

Treatable and preventable – and virtually eradicated in the U.S. – MDR-TB typically afflicts people in low-to middle-income countries. Like the name implies, MDR-TB is resistant to most antibiotics that work against TB.

Video News Release: Lilly Foundation Commits US $30 Million to Fight MDR-TB

Blog

The Lilly Foundation has committed US $30 million to The Lilly MDR-TB Partnership over the next five years (2012 to 2016). This funding will be used to advance the partnership's efforts in two key areas of focus: training for health care providers and improving supply and access to safe, effective, and quality-assured second-line medicines. Watch our video news release to see how The Lilly MDR-TB Partership is making a difference in the lives of people and communities most affected by multidrug-resistant tuberculosis.

Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership

Funding continues partnership’s fight against multidrug-resistant tuberculosis
Press Release

(3BL Media / theCSRfeed) Lille, France – October 27, 2011 – The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis, a disease that disproportionately affects developing countries and kills more than 150,000 people each year. The announcement was made ahead of the opening of the 42nd Union World Conference on Lung Health in Lille, France, later this week.

LillyPad, Our Company Blog: Improving Lives, Improving Lilly – Shared Value in Action

Blog

September 14, 2011 | By: David Marbaugh

You may have seen me or Rob Smith blogging about shared value and how it’s the wave of the future for corporate responsibility. And you may have thought, “OK, Sounds good. But why the heck do they keep going on about it?”

Video: Lilly Joins Global Fight to Combat Non-Communicable Diseases in Developing Countries

Summary: 

Through The Lilly NCD Partnership, we are investing $30 million to fight the rising burden of non-communicable diseases in developing countries. We invite you to watch our video. Then learn more at http://elil.ly/1u7z.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

LILLY16727

Press Release

Through The Lilly NCD Partnership, we are investing $30 million to fight the rising burden of non-communicable diseases in developing countries. We invite you to watch our video. Then learn more at http://elil.ly/1u7z.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

LILLY16727

Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases

The Lilly NCD Partnership will seek innovative solutions to help fight chronic diseases in developing countries
Press Release

(3BL Media / theCSRfeed) Indianapolis, IN - September 14, 2011 - Eli Lilly and Company (NYSE: LLY) announced today a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company’s unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people.

Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common Form of Lung Cancer

Press Release

(3BL Media / theCSRfeed) INDIANAPOLIS - July 22, 2011 - Eli Lilly and Company (NYSE: LLY) announced that it has made a charitable contribution to the Patient Advocate Foundation (PAF). The donation will enable expansion of the foundation's patient services programs, including Case Management and Co-Pay Relief (CPR) Programs in support of a new fund for patients with nonsquamous non-small cell lung cancer (NSCLC), the most common form of lung cancer.  

Pages

Subscribe to Lilly